No Detail Found!

Frequency of Disease Subsets and Spectrum of Organ Involvement and Interstitial Lung Disease Patterns in Patients of Systemic Sclerosis in Pakistani Population

Author(s)
Umbreen Arshad Department of Rheumatology, Central Park Teaching Hospital,Lahore,Pakistan
Muhammad Ahmed Saeed Department of Rheumatology, Arthritis Care Foundation,Lahore,Pakistan;Department of Rheumatology, Central Park Teaching Hospital,Lahore,Pakistan;Department of Rheumatology, National Hospital and Postgraduate Medical Centre,Lahore,Pakistan
Muhammad Rafaqat Hameed Department of Rheumatology, Arthritis Care Foundation,Lahore,Pakistan;Department of Rheumatology, Central Park Teaching Hospital,Lahore,Pakistan;Department of Rheumatology, National Hospital and Postgraduate Medical Centre,Lahore,Pakistan
Maryam Aamer Department of Rheumatology, Central Park Teaching Hospital,Lahore,Pakistan
Shamas U Din Department of Rheumatology, Arthritis Care Foundation,Lahore,Pakistan
Haflz Yasir Qamar Department of Rheumatology, Central Park Teaching Hospital,Lahore,Pakistan
Abstract
To assess the frequency of disease subsets and the spectrum of organ involvement, particularly focusing on interstitial lung disease (ILD) patterns among patients with systemic sclerosis (SSc). Study Design: Observational study. Place and Duration of the Study:Institute of Rheumatic Diseases, Central Park Teaching Hospital, and its a liated Arthritis Care Centre, Lahore, Pakistan, from July 2022 to December 2023. Methodology: Data were extracted from electronic records and gathered using a questionnaire. Patients were classi ed into limited cutaneous systemic sclerosis (lcSSc) and di use cutaneous systemic sclerosis (dcSSc) subsets based on clinical criteria. Gender, age, duration of disease, clinical features, and ILD patterns were compared between the groups. Results: The mean age of the 68 (88.3%) female patients was 37.9 ± 11.2 years. Younger patients presented with di use scleroderma (36 ± 11.3 years) compared to those with limited scleroderma (40.2 ± 10.7 years). The most common clinical feature was Raynaud s phenomenon (90.9%), followed by digital ulcers (41.6%). ILD was present in 68.8%, with non-speci c interstitial pneumonia (NSIP) identi ed in 31.2%, usual interstitial pneumonia (UIP) in 19.5%, and brosing NSIP in 3.9%. Conclusion: Systemic sclerosis predominantly a ects younger females, with a higher di use cutaneous subtype. Raynaud s phenomenon is the most common manifestation. ILD is a signi cant complication, with NSIP being the most common pattern observed.
Publication Details
Page(s) 646-650
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Rheumatic diseases, Limited cutaneous systematic sclerosis, Di use cutaneous systematic sclerosis
References
Asif S,Khan A,Faiq M,Din ZU,Zahoor S,Haroon M. .2021 .Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan. Arch Rheumatol, 8701(4) : 587-94.
Pope JE,Denton CP,Johnson SR,Codina AF,Hudson M,Nevskaya T .2023 .State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol, 10(4) : 212-26.
Bairkdar M,Rossides M,Westerlind H,Hesselstrand R,Arkema EV,Holmqvist M. Incidence .2021 .and prevalence of systemic sclerosis globally: A comprehensive systematic review and meta-analysis. Rheumatology (Oxford), 10(7) : 3121-33.
Volkmann ER,Andreasson K,Smith V .2023 .Systemic sclerosis. Lancet, 6736(22) : 01692-0.
Hunzelmann N,Genth E,Krieg T,Lehmacher W,Melchers I,Meurer M .2008 .The registry of the German network for systemic scleroderma: Frequency of disease subsets and patterns of organ involvement. Rheumatolology, 10(8) : 1185-92.
de Angelis R,Ferri C,Giuggioli D,Bajocchi G,Dagna L,Randone SB .2023 .9:e002890. RMD Open, 10 : .
Sobolewski P,Maslinska M,Wieczorek M,Lagun Z,Malewska A,Roszkiewicz M .2019 .Systemic sclerosis - multidisciplinary disease: Clinical features and treatment. Reumatologia, 87619(4) : 221-33.
Khanna D,Lescoat A,Roofeh D,Bernstein EJ,Kazerooni EA,Roth MD .2022 .Systemic sclerosis associated interstitial lung disease: How to incorporate two food and drug administration- approved therapies in clinical practice. Arthritis Rheumatol, 10(1) : 13-27.
Alam F,Abdulaziz HM,Haq IU,Mahdy SM,Siam ARM,Chandra P .2019 .3):16. Qatar Med J, 16 : .
Coi A,Barsotti S,Santoro M,Almerigogna F,Bargagli E,Caproni M .2021 .Epidemiology of systemic sclerosis: A multidatabase population-based study in Tuscany (Italy). Orphanet J Rare Dis, 10(1) : 90.
El Basel M,Khalil N. .2015 .Disease characteristics of systemic sclerosis among Egyptian patients. Kasr Al Ainy Med J, 10(2) : 162378-4625.
Elbraky FM,Amailaf IA,Alsaeiti K. .2020 .Demographic characteristics and clinical manifestations of systematic sclerosis in Benghazi, Libya. Ibnosina J Med Biomed Sci, 36(2) : 20-22.
Horimoto AMC,Matos ENN,da Costa MR,Takahashi F,Rezende MC,Kanomata LB .2016 .Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil. Rev Bras Reumatol, 09(2) : 107-14.
Hughes M,Herrick AL .2019 .Systemic sclerosis. Br J Hosp Med, 80(9) : 530-6.
Li H,Zhang X,Yu L,Shang J,Fan J,Feng X .2022 .Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese rheumatism data center. Front Med, 1061738 : 1061738.
Khaliq T,Aziz W,Farooqi A .2014 .Spectrum of systemic sclerosis in patients presenting to a tertiary care hospital in Pakistan. Pak Armed Forces Med J, 64(4) : 591-5.
Jafri S,Ahmed N,Saifullah N,Musheer M. Epidemiology .2020 .and clinico-radiological features of interstitial lung diseases. Pak J Med Sci, 10(3) : 365-70.
Zubairi ABS,Hassan M,Shahzad T,Sarwar S,Abbas A,Ahmad H .2017 .Spectrum of interstitial lung disease from a tertiary care hospital in Karachi. J Pak Med Assoc, 67(7) : 1065-9.
0

Citations

0

Downloads

129

Views